Roberto Ranza

1.4k total citations
35 papers, 612 citations indexed

About

Roberto Ranza is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Roberto Ranza has authored 35 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Rheumatology, 20 papers in Immunology and 14 papers in Hematology. Recurrent topics in Roberto Ranza's work include Spondyloarthritis Studies and Treatments (23 papers), Psoriasis: Treatment and Pathogenesis (17 papers) and Rheumatoid Arthritis Research and Therapies (17 papers). Roberto Ranza is often cited by papers focused on Spondyloarthritis Studies and Treatments (23 papers), Psoriasis: Treatment and Pathogenesis (17 papers) and Rheumatoid Arthritis Research and Therapies (17 papers). Roberto Ranza collaborates with scholars based in Brazil, United States and United Kingdom. Roberto Ranza's co-authors include Laura C. Coates, Philip J. Mease, Antonio Marchesoni, Luis R. Espinoza, Neil McHugh, Oliver FitzGerald, Euthalia Roussou, Enrique R. Soriano, María Laura Acosta Felquer and Philip Helliwell and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Roberto Ranza

33 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Ranza Brazil 13 481 315 254 45 42 35 612
Sofia Exarchou Sweden 11 454 0.9× 230 0.7× 101 0.4× 52 1.2× 50 1.2× 32 576
Andreas Gerards Netherlands 14 440 0.9× 136 0.4× 177 0.7× 11 0.2× 34 0.8× 19 536
Tor Magne Madland Norway 11 415 0.9× 171 0.5× 137 0.5× 16 0.4× 35 0.8× 15 574
Violeta Bojincă Romania 13 219 0.5× 146 0.5× 65 0.3× 31 0.7× 78 1.9× 64 426
L. Zakraoui Tunisia 11 249 0.5× 99 0.3× 85 0.3× 18 0.4× 65 1.5× 60 441
Elinor Mody United States 10 395 0.8× 357 1.1× 199 0.8× 74 1.6× 20 0.5× 15 529
Ivet Etchegaray‐Morales Mexico 13 342 0.7× 174 0.6× 50 0.2× 21 0.5× 110 2.6× 62 534
Meryem Can Türkiye 15 272 0.6× 113 0.4× 107 0.4× 9 0.2× 89 2.1× 36 446
H Zeidler Germany 12 507 1.1× 217 0.7× 135 0.5× 31 0.7× 38 0.9× 36 645
J. Sieper Germany 8 520 1.1× 287 0.9× 132 0.5× 9 0.2× 60 1.4× 15 585

Countries citing papers authored by Roberto Ranza

Since Specialization
Citations

This map shows the geographic impact of Roberto Ranza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Ranza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Ranza more than expected).

Fields of papers citing papers by Roberto Ranza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Ranza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Ranza. The network helps show where Roberto Ranza may publish in the future.

Co-authorship network of co-authors of Roberto Ranza

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Ranza. A scholar is included among the top collaborators of Roberto Ranza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Ranza. Roberto Ranza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coates, Laura C., Ricardo Blanco, Frank Behrens, et al.. (2025). Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies. RMD Open. 11(3). e005522–e005522.
2.
3.
4.
Baraliakos, Xenofon, Roberto Ranza, Andrew J.K. Östör, et al.. (2023). Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies. Arthritis Research & Therapy. 25(1). 56–56. 10 indexed citations
5.
Eder, Lihi, Ashish Jacob Mathew, Philippe Carron, et al.. (2022). Management of Enthesitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. The Journal of Rheumatology. 50(2). 258–264. 10 indexed citations
6.
Baraliakos, Xenofon, Roberto Ranza, Andrew J.K. Östör, et al.. (2022). POS0934 EFFICACY OF UPADACITINIB ON PSORIATIC ARTHRITIS WITH AXIAL INVOLVEMENT DEFINED BY INVESTIGATOR ASSESSMENT AND PRO-BASED CRITERIA: RESULTS FROM TWO PHASE 3 STUDIES. Annals of the Rheumatic Diseases. 81. 768–768. 3 indexed citations
7.
Gossec, Laure, Dafna D. Gladman, Philipp Sewerin, et al.. (2021). AB0550 EFFICACY OF UPADACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND A LOW OR HIGH SWOLLEN JOINT COUNT: A SUBGROUP ANALYSIS OF 2 PHASE 3 STUDIES (SELECT-PsA 1 AND SELECT-PsA 2). Annals of the Rheumatic Diseases. 80. 1308–1309. 1 indexed citations
8.
Strand, Vibeke, Filip Van den Bosch, Roberto Ranza, et al.. (2021). Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2. Rheumatology and Therapy. 8(4). 1827–1844. 14 indexed citations
9.
Carneiro, Sueli Coelho da Silva, et al.. (2020). Validation and clinical interpretability of PsAID - psoriatic arthritis impact of disease. Advances in Rheumatology. 60(1). 49–49. 11 indexed citations
10.
Goldenstein‐Schainberg, Cláudia, Sueli Carneiro, Ricardo Romiti, et al.. (2018). Semantic and psychometric validation of the Brazilian Portuguese version (PASE-P) of the Psoriatic Arthritis Screening and Evaluation questionnaire. PLoS ONE. 13(10). e0205486–e0205486. 6 indexed citations
11.
12.
Ranza, Roberto, Sueli Carneiro, Abrar A. Qureshi, et al.. (2015). Prevalence of Psoriatic Arthritis in a Large Cohort of Brazilian Patients with Psoriasis. The Journal of Rheumatology. 42(5). 829–834. 37 indexed citations
13.
Felquer, María Laura Acosta, Laura C. Coates, Enrique R. Soriano, et al.. (2014). Drug Therapies for Peripheral Joint Disease in Psoriatic Arthritis: A Systematic Review. The Journal of Rheumatology. 41(11). 2277–2285. 33 indexed citations
14.
Carneiro, Sueli, Valderílio Feijó Azevedo, Rubens Bonfiglioli, et al.. (2013). Recommendations for the management and treatment of psoriatic arthritis. Revista Brasileira de Reumatologia (English Edition). 53(3). 227–241. 13 indexed citations
15.
Sampaio‐Barros, Percival D., Mauro Waldemar Keiserman, Eduardo de Souza Meirelles, et al.. (2013). Recommendations for the management and treatment of ankylosing spondylitis. Revista Brasileira de Reumatologia (English Edition). 53(3). 242–257. 10 indexed citations
16.
Ranza, Roberto, et al.. (2009). Autoimmune Thyroiditis and Rheumatoid Arthritis. The Endocrinologist. 19(1). 31–34. 8 indexed citations
17.
Diniz, Angélica Lemos Debs, et al.. (2009). Hiperperfusão no território orbital de gestantes portadoras de lúpus eritematoso sistêmico. Revista Brasileira Ginecologia e Obstetrícia. 31(11). 534–539. 2 indexed citations
18.
Pigatto, P. D., et al.. (1994). Methotrexate in psoriatic polyarthritis.. PubMed. 186. 114–5. 7 indexed citations
19.
Marchesoni, Antonio, L. Sinigaglia, Roberto Ranza, et al.. (1993). Rifamycin SV Versus Triamcinolone in Local Treatment of Rheumatoid Synovitis. Scandinavian Journal of Rheumatology. 22(4). 194–198. 11 indexed citations
20.
Sakkas, Lazaros I., Antonio Marchesoni, Roberto Ranza, et al.. (1991). IMMUNOGLOBULIN HEAVY CHAIN GENE POLYMORPHISMS IN ITALIAN PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS. Lara D. Veeken. 30(6). 449–450. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sofia Exarchou Breakdown of academic impact, for papers by Andreas Gerards Breakdown of academic impact, for papers by Tor Magne Madland Breakdown of academic impact, for papers by Violeta Bojincă Breakdown of academic impact, for papers by L. Zakraoui Breakdown of academic impact, for papers by Elinor Mody Breakdown of academic impact, for papers by Ivet Etchegaray‐Morales Breakdown of academic impact, for papers by Meryem Can Breakdown of academic impact, for papers by H Zeidler Breakdown of academic impact, for papers by J. Sieper
Rankless by CCL
2026